Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.75 -8.75% 18.25 17.50 19.00 19.75 17.75 19.75 1,147,084 13:13:31
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -11.1 -4.4 - 45

Futura Medical Share Discussion Threads

Showing 16701 to 16722 of 19950 messages
Chat Pages: Latest  678  677  676  675  674  673  672  671  670  669  668  667  Older
DateSubjectAuthorDiscuss
10/4/2019
15:57
tiananmen that is exactly what FUM said about CSD500 the 'viagra' condom and look what happened to that - nothing, except revenue down from £360K in 2017 to ZERO in 2018 ! - at least in 2017 it covered Barders 1/4million+ remuneration ! From todays report :- CSD500 - condom containing the erectogenic Zanifil(R) gel In September 2018, Futura received approval for a two-year shelf life for CSD500 for its European contract condom manufacturer. This milestone provides the company with an opportunity to focus its R&D resource fully on the far greater potential of its leading asset, MED2005. As an innovative specialist R&D company, Futura does not have the marketing or regulatory medical device resource available to support the day-to-day requirements in a growing compliance-driven market and is in discussions with potential partners to assume these obligations. Futura expects to still benefit from the Intellectual Property of CSD500 through potential royalties, but the immediate potential for substantial royalties is low in the absence of a large global brand 'carrier' to take the product forward as previously advised. The Company will continue to explore national, multi-territory and regional agreements where the opportunities arise. The Company is expected to benefit from annual cost savings of approximately GBP400k in the event that it no longer maintains regulatory clearance itself for CSD500 as a medical device. - don't hold your breath !
mikethebike4
10/4/2019
14:38
We were not expecting anything significant from today's announcement and that is what we got. We still have to wait until the Phase III results are finished until it gets approval, nothing has changed, the early signs is that this drug is going to make a substantial impact on the market.
tiananmen
10/4/2019
12:57
That is for the USAFirst one is for Europe and we are half way stage.15% royalties on $1.4 billion peak sales is $210,000,000 a year.That is 5 times current market cap annually.All to play for.
j777j
10/4/2019
12:30
They also said... "Planning for a SECOND, CONFIRMATORY Phase 3 study for MED2005 has been UNDERTAKEN.. ... THIS STUDY is expected to be informed by the FIRST Phase 3 and therefore START AFTER END of the FIRST PHASE 3 STUDY... The way I see it - 'POTENTIAL' and 'EXECUTION' are two totally different beasts. Only time will tell. ATB
5oletrader
10/4/2019
11:26
Meanwhile back in the real world,it is all systems go for a product that could generate 15% royalties on peak sales of $1.4 billion pa."Futura medical confirmed it will deliver the results from its phase III trial for a fast-acting gel for erectile dysfunction (ED) by the end of the year, a milestone which expects to be a "major value inflection point". The first of two studies of MED2005 got underway in October treating 1,000 men at 60 centres across Europe. Headline data should be released towards the back-end of 2019, the company said."
j777j
10/4/2019
09:28
It's incompetence, barder background is insurance, he has no experience exploiting technology, if the board was credible it would have replaced him but they are his appointees.
slicethepie
10/4/2019
09:26
Futura Medical plc James Barder, Chief Executive mail to: james.barder@futuramedical.com
lbo
10/4/2019
08:47
there's 12 months of cash left....that's it. there is nothing in the statement that shows any material progress in the last 12 months, a research paper and chinwagging with a few 'luminaries' hardly counts as progress.... After the recent ramping, expect another cash call in Q4 at about 4p...
savagedstock
10/4/2019
08:25
You have to own this despite barder, he could turn gold into lead, there is real value here BUT he is so out of his depth that we could end up with nothing!
slicethepie
09/4/2019
12:14
Pre results shake out of weak holders.Happens every time.15% royalty on projected $1.4 billion peak sales is $210 million pa.In it to win it.
j777j
09/4/2019
10:17
presumably usual suspects selling
wantage
09/4/2019
08:13
o dear maybe 10p at the close
sibeks
08/4/2019
09:43
Maybe the close then?Amazing here is a co with a potential blockbuster drug which could see peak sales of $1.4 billion a year with a market cap at what would be a couple of months royalties!You don't see that very often.
j777j
07/4/2019
18:21
20p tomorrow on the open.
sibeks
03/4/2019
19:04
Firming up
penciles2
02/4/2019
12:17
Nice to see some movement. Certainly moves quickly!
markymanc
02/4/2019
11:47
I guess hence the further two top 5 European pharmas co's signing up for Tpr100 has been forecast for this year by the house broker Singer.
j777j
02/4/2019
10:37
Thanks re TPR timescale J777J.
rrr
02/4/2019
08:17
Tpr was submitted last July and takes around a year,So getting close.Hopefully plenty of news in next week or so.
j777j
02/4/2019
08:14
steady buying today - prelims. on the 10th ? - might get some 'deal' news
mikethebike4
29/3/2019
09:32
The only thing I can find is that TPR100 response from UK regulators is expected in 2019, is there any other information as to more precisely when it may be?
rrr
26/3/2019
17:10
And of course the results and webcast on 10/4 may shed some more light on things.
rrr
Chat Pages: Latest  678  677  676  675  674  673  672  671  670  669  668  667  Older
ADVFN Advertorial
Your Recent History
LSE
FUM
Futura Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210309 00:44:59